Insider buying last 90 days
No open-market insider purchases were filed for A in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Agilent completed its $240 million cash acquisition of Proscia, a digital pathology software company, with up to $30 million in additional performance-based payments; the deal brings Proscia's Concentriq platform into Agilent's Life Sciences and Diagnostics Markets Group. Separately, Agilent launched its Altura Ultra Inert HPLC column range for biotherapeutic applications, and Argus raised its price target on the stock to $190.00 on October 21.
Agilent (A) closed at $177.17, up 1% on the day, and sits above both its 50-day average of $165.23 and its 200-day average of $136.58, with the shorter average above the longer one. The GekkoIndex reads 54.4, placing it in the Neutral zone, up 4.6 over five days. The stock trades 25.6% above Gekko Fair Value of $141.05.
Agilent's next earnings report is due 23 November 2026 after close, 18 days out and inside a typical 20-trading-day holding window; its last report beat EPS estimates by $0.06 with a 1.9% reaction. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows, though one billionaire holder and one trailblazer holder are recorded. Seasonality over the next 20 trading days has averaged 5.4% across 5 years, rising in 3 of them. Analyst consensus stands at 13 buy, 3 hold, 0 sell ratings, with a consensus target of $182.05.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Agilent Technologies scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
Above 50 and 200-day
Close $177.17 is above the 50-day ($165.23) and 200-day ($136.58) averages, and the 50-day is above the 200-day.
See the chart54.4, Neutral
Reading 54.4 is in the Neutral zone.
See the GekkoIndex25.6% above
Price is 25.6% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 18 days
Reports on Nov 23, 2026, 18 days away — inside a typical 20-trading-day hold.
See earnings+5.4% on average
From this point in the calendar, the next 20 trading days averaged +5.4% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Agilent Technologies closed at $177.17 on Nov 4, 2026, +22.4% over the past year, inside a 52-week range of $108.35 to $182.99.
Use the left and right arrow keys to read daily values.
Put A on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Agilent Technologies builds instruments, consumables and software used for laboratory analysis in life sciences, diagnostics and applied chemistry. It is best known for chromatography and mass spectrometry equipment, including liquid and gas chromatography systems that pair with mass spectrometry for detailed chemical analysis, along with spectroscopy tools such as inductively coupled plasma, atomic absorption and Raman instruments. Its catalog also covers cell analysis equipment like flow cytometers, imaging systems and microplate readers, plus lab software and automation tools.
The company organizes its work into three areas. One supplies the broad instrumentation and lab automation portfolio described above. Another, focused on diagnostics and genomics, makes arrays and sequencing-related products for genetic testing, tools for DNA and gene expression analysis, tissue staining products, custom oligonucleotides, and reagents and consumables used in nucleic acid quality control. The third, Agilent CrossLab, supplies chromatography columns, sample preparation products, chemical formulations and other consumables and services that support laboratory instruments.
Agilent Technologies trades on the NYSE under the ticker A.
Agilent Technologies’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.4, in the Neutral zone, up 4.6 points over five sessions.
Up 4.6 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 36 | +0.2% | −3.0% | ||
| Accumulation | 210 | +0.1% | +1.5% | ||
| Neutral (current zone) | 396 | +0.6% | +1.8% | ||
| Distribution | 54 | −0.7% | −1.9% | ||
| Selling | 1 | Too few readings yet | |||
Average A share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Agilent Technologies trades 25.6% above Gekko Fair Value of $141.05, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Agilent Technologies shares are worth, recalculated every trading day.
$141.05
Gekko Fair Value, Nov 4, 2026
25.6% Overvalued
At the end of Aug 2026 the price was 20.8% above the estimate.
No open-market insider purchases were filed for Agilent Technologies, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for A in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in A were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Agilent Technologies has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold A.
Agilent Technologies reports on Nov 23, 2026, after the close (18 days away), and beat the EPS estimate in 6 of its last 8 reports.
Nov 23, 2026
Expected after the close, 18 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 26, 2026 | $1.62 est $1.49 | $1.88B est $1.84B | +1.9% |
| May 27, 2026 | $1.49 est $1.41 | $1.84B est $1.80B | +17.6% |
| Feb 25, 2026 | $1.36 est $1.37 | $1.80B est $1.81B | −2.8% |
| Nov 24, 2025 | $1.59 est $1.58 | $1.84B est $1.83B | +3.9% |
| Aug 27, 2025 | $1.37 est $1.37 | $1.74B est $1.68B | +5.6% |
| May 28, 2025 | $1.31 est $1.26 | $1.67B est $1.63B | +1.8% |
| Feb 26, 2025 | $1.31 est $1.27 | $1.68B est $1.67B | −5.3% |
| Nov 25, 2024 | $1.46 est $1.41 | $1.70B est $1.67B | +0.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Agilent Technologies is $182.05, +2.8% from the last close, from 16 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 16 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 26 | Deutsche Bank | $190 | +7.2% |
| Oct 16 | Bernstein | $180 | +1.6% |
| Oct 14 | UBS | $180 | +1.6% |
| Oct 13 | Morgan Stanley | $190 | +7.2% |
| Oct 13 | TD Cowen | $196 | +10.6% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Agilent Technologies averaged +5.4% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.5% | 3 of 5 |
| Next 10 trading days | +0.7% | 3 of 5 |
| Next 15 trading days | +5.4% | 3 of 5 |
| Next 20 trading days | +5.4% | 3 of 5 |
| Next 30 trading days | +4.3% | 2 of 5 |
For scale, A’s typical 20-trading-day move in either direction is about 5.5%.
Agilent Technologies’s market cap is $49.96B, with a P/E ratio of 34.5 and revenue of $7.37B over the last twelve months.
Coverage of Agilent Technologies this week reads positive: 9 positive, 7 neutral and 2 negative headlines.
Agilent Technologies’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 14.5% above |
| ABTAbbott Laboratories | Distribution | 8.0% below |
| ISRGIntuitive Surgical | Distribution | 30.4% above |
| DHRDanaher | Neutral | 3.6% above |
| MDTMedtronic | Neutral | 16.0% below |
| SYKStryker | Distribution | 6.5% above |
A peer links to its own page where one exists.
Agilent Technologies’s market cap is $49.96B at the Nov 4, 2026 close of $177.17, with 282.0M shares outstanding. The shares trade on a P/E ratio of 34.5.
The consensus analyst 12-month price target for Agilent Technologies is $182.05, +2.8% from the last close. Of the 16 firms that rated the stock in the last 90 days, 13 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Agilent Technologies is overvalued: the Nov 4, 2026 close of $177.17 is 25.6% above Gekko Fair Value of $141.05. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Agilent Technologies is expected to report on Nov 23, 2026, after the market closes (18 days away). Analysts expect earnings of $1.73 per share on revenue of $1.99B. Agilent Technologies beat the earnings estimate in 6 of its last 8 reports, moving 4.9% on average across the report.
Agilent Technologies’s 52-week high is $182.99 and its 52-week low is $108.35; it closed at $177.17 on Nov 4, 2026, +22.4% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.